The Federal Trade Commission (FTC) has taken a significant step in its ongoing campaign against interlocking directorates, proposing a consent order to resolve allegations of an illegal arrangement between firearms manufacturers Beretta Holding and Sturm, Ruger & Company. This action, announced on Saturday, October 17, 2026, underscores the antitrust agencies’ sustained focus on enforcing Section 8 of the Clayton Act, which prohibits individuals from serving on the boards of competing companies. The proposed order stems from Beretta Holding’s minority acquisition of shares in Ruger, which included provisions for Beretta to appoint directors to Ruger’s board, thereby potentially creating an illegal interlocking directorate.
The FTC’s complaint detailed an agreement under which Beretta Holding, a subsidiary of Upifra, planned to increase its stake in Ruger to as much as 25% of Ruger’s outstanding shares. In return, Beretta secured contractual rights to designate directors for Ruger’s board. Specifically, the agreement stipulated that Ruger’s board "shall" appoint two directors nominated by Beretta. These appointees were to be included on Ruger’s slate of nominees for the company’s annual meetings in 2027 and 2028. This arrangement, the FTC contended, would violate Section 8 of the Clayton Act by establishing an illegal interlocking directorate, as Beretta and Ruger are direct competitors in the production and sale of firearms.
Understanding Interlocking Directorates and Section 8 of the Clayton Act
Section 8 of the Clayton Act is a stringent, strict liability statute designed to prevent undue influence and potential anticompetitive coordination between rival companies. It explicitly forbids the same individual from holding an officer or director position in two competing corporations. Crucially, the statute does not require proof of actual anticompetitive effects; its violation is established by the mere existence of the prohibited interlock. Antitrust agencies have consistently interpreted the term "person" in this context to extend beyond individuals directly holding positions in both companies, encompassing "representatives" of those corporations.
The prohibition under Section 8 is triggered when two companies are in competition with each other and meet certain statutory size thresholds, unless specific "de minimis" exceptions apply. These exceptions are generally designed to exempt situations where the overlap in sales between the competing companies is minimal, either in absolute dollar amounts or as a percentage of their total sales. Furthermore, Section 8 includes a one-year grace period, allowing companies time to unwind an interlock that becomes unlawful due to unforeseen changes in circumstances, such as a transaction that significantly increases competitive sales above the established thresholds.
The Beretta-Ruger Allegations and FTC Scrutiny
The FTC’s complaint asserted that the agreement between Beretta and Ruger would create an illegal interlocking directorate, a violation of Section 8 of the Clayton Act. Additionally, the agency alleged that such an arrangement constitutes an unfair method of competition under Section 5 of the FTC Act. The complaint highlighted that Beretta and Ruger operate as horizontal competitors across numerous categories of firearms, a fact that Ruger itself had reportedly acknowledged in its public securities filings.
A particular point of contention for the FTC was the nature of the board designees. While the agreement nominally required Beretta’s designated directors to be "independent," the FTC expressed concern that the safeguards for independence were not robust enough. The agreement also reportedly permitted waivers of certain independence requirements, which could potentially allow individuals affiliated with Beretta, or other non-independent parties, to sit on Ruger’s board. It is noteworthy that the FTC did not allege that Beretta intended to appoint one of its own officers or directors directly to the Ruger board. Instead, the primary focus of the FTC’s concern appeared to be the perceived inadequacy of the "fulsome requirements" for director independence. The proposed order, importantly, does not completely eliminate Beretta’s right to appoint directors but imposes significant structural safeguards.
Broader Enforcement Context and Recent Actions
The Beretta-Ruger case is not an isolated incident but rather a signal of a broader, intensified enforcement posture by antitrust agencies. This action follows closely on the heels of other recent FTC initiatives aimed at curbing interlocking directorates. In September 2025, the FTC announced that three individuals had resigned from the board of Sevita Health in response to the agency’s scrutiny of their roles. These resignations occurred amidst ongoing FTC enforcement efforts targeting such arrangements.
Furthermore, there have been unconfirmed reports that the Department of Justice (DOJ) is actively investigating a venture capital firm for potential violations of Section 8. While details remain scarce, this reported investigation suggests that the DOJ is also prioritizing the enforcement of interlocking directorate prohibitions, signaling a coordinated effort across federal antitrust agencies to address this issue. This heightened activity indicates a shift in regulatory focus and a commitment to proactively preventing potential competitive harm arising from such arrangements.
Proposed Consent Order and Structural Safeguards
The proposed consent order in the Beretta-Ruger matter allows the transaction to proceed but imposes significant structural safeguards on Beretta’s board appointment rights. These safeguards are designed to mitigate the risks of anticompetitive coordination and ensure that the appointed directors act independently and in the best interests of Ruger and its shareholders, rather than serving the interests of Beretta.
The specific safeguards mandated by the order include:
- Independent Director Qualifications: Any individual appointed by Beretta to Ruger’s board must meet stringent independence requirements. These requirements are designed to ensure that the director has no material relationship with Beretta, its affiliates, or its officers and directors, other than their directorship on Ruger’s board. This aims to prevent individuals with existing business ties or loyalties to Beretta from influencing Ruger’s strategic decisions.
- Board Responsibilities and Fiduciary Duty: The appointed directors will be explicitly required to uphold their fiduciary duties to Ruger and its shareholders. This reinforces the principle that their primary allegiance must be to Ruger, not to Beretta, and that they must act in a manner that benefits Ruger’s overall business interests.
- Limitations on Information Sharing: The order likely includes provisions to prevent the inappropriate flow of competitively sensitive information between Beretta and Ruger through the appointed directors. This could involve restrictions on the types of information these directors can share with Beretta or limitations on their participation in discussions concerning sensitive competitive strategies.
- Regular Compliance Reporting: Beretta is obligated to provide interim and annual compliance reports to the FTC for the duration of the order. This reporting mechanism allows the FTC to monitor Beretta’s adherence to the stipulated safeguards and to identify any potential breaches or circumventions of the agreement.
- Ongoing Training and Awareness: Beretta must ensure that the proposed consent order is circulated to its new board members and officers on an ongoing basis. This requirement aims to foster a culture of compliance within Beretta and to ensure that all relevant personnel are aware of the restrictions and obligations imposed by the order.
The proposed order is set to run for a period of five years, during which Beretta will be subject to these ongoing reporting and compliance obligations. This timeframe allows for sustained oversight and ensures that the safeguards remain in effect for a substantial period, providing ample opportunity to assess their effectiveness.
Implications and Broader Impact
The FTC’s proactive stance in the Beretta-Ruger case, and its broader enforcement actions, carry significant implications for corporate governance and antitrust compliance across various industries.
- Increased Scrutiny of Minority Investments and Board Representation: This action signals a heightened level of scrutiny for minority investments that include provisions for board representation, particularly in industries where companies are direct competitors. Companies considering such arrangements must now conduct a more thorough antitrust analysis to ensure compliance with Section 8 of the Clayton Act.
- Emphasis on Genuine Independence: The FTC’s focus on the "fulsome requirements" for director independence highlights the critical need for robust safeguards in any situation involving board appointments by a significant shareholder in a competing entity. Nominal independence will likely no longer suffice; regulators will demand demonstrable mechanisms to ensure true autonomy.
- Deterrent Effect: The FTC’s aggressive enforcement, coupled with reported DOJ investigations, is likely to have a deterrent effect on other companies considering similar interlocking directorate arrangements. Businesses will need to be more cautious and proactive in seeking legal counsel to navigate these complex antitrust regulations.
- Potential for Industry-Wide Compliance Reviews: In industries with significant competitive overlap, such as firearms manufacturing, this enforcement action could prompt broader compliance reviews by companies. The market may see an increase in proactive internal investigations and adjustments to corporate governance structures to preemptively address potential antitrust concerns.
- Impact on Capital Markets: For investors and companies involved in mergers, acquisitions, and strategic investments, this trend suggests a more challenging regulatory landscape. The antitrust review process may become more protracted and complex, potentially influencing deal structuring and timelines.
The proposed consent order represents a delicate balance: it allows for a minority investment to proceed while implementing stringent controls to safeguard competitive markets. The success of these safeguards will be closely watched by the business community and antitrust enforcers alike. As regulatory agencies continue to prioritize the enforcement of interlocking directorate prohibitions, companies must remain vigilant and ensure their corporate governance practices align with evolving antitrust expectations. The ultimate goal is to foster a competitive environment where innovation and consumer welfare are paramount, free from the undue influence or coordination that interlocking directorates can facilitate.
